Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases

BACKGROUND: In breast cancer current guidelines do not recommend the routine use of serum tumour markers. Differently, we observed that CEA-TPA-CA15.3 (carcinoembryonic (CEA) tissue polypeptide (TPA) and cancer associated 115D8/DF3 (CA15.3) antigens) panel permits early detection and treatment for m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nicolini, Andrea, Tartarelli, Gianna, Carpi, Angelo, Metelli, Maria Rita, Ferrari, Paola, Anselmi, Loretta, Conte, Massimo, Berti, Piero, Miccoli, Paolo
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2006
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1684262/
https://ncbi.nlm.nih.gov/pubmed/17116247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-269
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares